Last 48 quarters of trend data · Healthcare · Specialty & Generic Drugs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.70 | 1.27 | 1.81 | — | — | 3.43 | 4.16 | — | 8.06 | — | 64.54 | — | — | — | 27.89 | — | — | 1.57 | — | — | 36.33 |
| — | -63.1% | -56.5% | — | — | — | -93.6% | — | — | — | +131.4% | — | — | — | — | — | — | -88.3% | — | — | — | |
| P/S Ratio | 0.27 | 0.19 | 0.16 | 0.20 | 0.23 | 0.23 | 0.25 | 0.26 | 0.29 | 0.30 | 0.27 | 0.45 | 0.30 | 0.34 | 0.34 | 0.38 | 0.26 | 0.31 | 0.39 | 1.07 | 1.14 |
| — | -16.5% | -33.5% | -24.7% | -21.4% | -24.6% | -8.5% | -41.4% | -3.7% | -10.8% | -20.8% | +19.4% | +17.4% | +9.7% | -12.0% | -64.8% | -77.4% | -74.5% | -69.2% | -24.5% | +35.7% | |
| P/B Ratio | 8.15 | — | — | — | 6.84 | 6.81 | 16.90 | — | — | — | — | — | — | — | 14.36 | 20.29 | 8.74 | 5.78 | 11.98 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | +19.8% | — | — | — | — | — | — | |
| P/FCF | 1.67 | 0.74 | 0.79 | 6.06 | 1.60 | 1.93 | 3.27 | 6.87 | 1.52 | 2.26 | 2.15 | 7.60 | 2.98 | 3.18 | 4.09 | 7.14 | 1.52 | — | 20.43 | — | — |
| — | -61.5% | -76.0% | -11.8% | +5.4% | -14.7% | +52.4% | -9.6% | -49.0% | -28.9% | -47.5% | +6.4% | +95.4% | — | -80.0% | — | — | — | +129.6% | — | — | |
| EV / EBITDA | 5.39 | 4.04 | 4.93 | 6.59 | 5.02 | 5.87 | 7.36 | 9.53 | 6.77 | 9.29 | 8.36 | 10.50 | 8.82 | 19.58 | 6.19 | 11.68 | 45.31 | 10.03 | 11.90 | 11.84 | 11.00 |
| — | -31.2% | -33.0% | -30.9% | -25.9% | -36.9% | -12.0% | -9.2% | -23.2% | -52.5% | +35.0% | -10.1% | -80.5% | +95.2% | -48.0% | -1.3% | +311.9% | +20.6% | -80.8% | -75.1% | -39.5% | |
| EV / EBIT | 10.50 | 5.14 | 7.00 | — | 12.40 | 8.77 | 9.30 | 20.11 | 9.86 | 10.93 | 13.88 | 21.10 | 12.02 | 12.49 | 11.82 | 25.42 | 13.13 | 15.37 | 21.14 | 22.71 | 16.26 |
| — | -41.4% | -24.7% | — | +25.7% | -19.8% | -33.0% | -4.7% | -17.9% | -12.4% | +17.4% | -17.0% | -8.5% | -18.7% | -44.1% | +11.9% | -19.3% | -19.4% | -16.7% | +4.5% | -5.6% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.7% | 75.0% | 72.9% | 70.8% | 71.5% | 72.0% | 69.8% | 69.0% | 71.6% | 72.3% | 70.1% | 70.3% | 70.7% | 72.2% | 70.1% | 70.1% | 70.3% | 71.5% | 70.7% | 71.3% | 71.5% |
| — | +4.1% | +4.5% | +2.6% | -0.2% | -0.3% | -0.4% | -1.9% | +1.2% | +0.2% | +0.0% | +0.3% | +0.6% | +1.0% | -0.9% | -1.7% | -1.7% | -1.3% | -0.3% | -0.6% | +0.9% | |
| Operating Margin | 21.3% | 33.4% | 27.2% | 20.6% | 29.6% | 23.7% | 18.1% | 12.9% | 21.8% | 12.7% | 16.2% | 13.1% | 15.0% | 0.6% | 19.0% | 9.0% | -10.8% | 11.9% | 8.2% | 14.9% | 16.7% |
| — | +40.9% | +50.4% | +59.7% | +36.0% | +87.2% | +11.6% | -1.0% | +45.0% | +1925.1% | -14.9% | +45.0% | +239.7% | -94.8% | +132.3% | -39.4% | -164.4% | -56.1% | +163.7% | +236.3% | +7498.1% | |
| Net Margin | 1.5% | 14.8% | 9.0% | -56.4% | -4.0% | 6.7% | 5.8% | -2.6% | 3.6% | -3.4% | 0.4% | -3.0% | -1.6% | -16.9% | 1.2% | -10.3% | -18.7% | 19.5% | -7.4% | -3.6% | 3.1% |
| — | +122.0% | +54.6% | -2095.9% | -210.2% | +297.2% | +1305.9% | +13.2% | +324.4% | +79.9% | -65.3% | +71.4% | +91.3% | -186.6% | +116.3% | -187.4% | -695.0% | +119.0% | +74.0% | +88.0% | +145.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 578.1% | — | — | — | -30.6% | 71.2% | 100.7% | — | — | — | — | — | — | — | 14.9% | -99.3% | -118.3% | 116.3% | -258.9% | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | +105.7% | — | — | — | — | — | — | |
| ROA | 0.6% | 1.7% | 1.0% | -5.6% | -0.4% | 0.7% | 0.6% | -0.2% | 0.4% | -0.3% | 0.0% | -0.2% | -0.1% | -1.6% | 0.1% | -0.8% | -1.6% | 1.5% | -0.5% | -0.2% | 0.2% |
| — | +161.9% | +89.9% | -2456.2% | -220.3% | +306.6% | +1374.1% | +6.7% | +344.6% | +80.4% | -67.8% | +70.1% | +90.9% | -211.4% | +123.0% | -232.2% | -768.1% | +131.1% | +74.4% | +88.1% | +148.4% | |
| ROIC | 8.1% | 4.1% | 3.2% | 2.0% | 3.1% | 2.4% | 1.7% | 1.1% | 2.1% | 1.2% | 1.4% | 1.0% | 1.3% | 0.1% | 1.7% | 0.6% | -0.9% | 0.9% | 0.6% | 1.0% | 1.3% |
| — | +72.4% | +86.9% | +85.7% | +49.9% | +105.9% | +22.5% | +9.8% | +62.2% | +1915.0% | -20.1% | +53.8% | +249.2% | -93.3% | +210.8% | -34.0% | -167.3% | -56.3% | +162.3% | +237.9% | +8199.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 56.36 | — | — | — | 56.36 | 59.11 | 147.88 | — | — | — | — | — | — | — | 75.84 | 142.43 | 79.87 | 49.00 | 86.22 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | -12.0% | — | — | — | — | — | — | |
| Debt / EBITDA | 6.25 | 16.35 | 19.68 | 25.48 | 18.95 | 22.32 | 28.45 | 36.03 | 24.99 | 33.60 | 30.64 | 36.73 | 32.40 | 71.21 | 21.34 | 41.81 | 167.47 | 36.64 | 42.94 | 36.37 | 31.03 |
| — | -26.7% | -30.8% | -29.3% | -24.2% | -33.6% | -7.1% | -1.9% | -22.9% | -52.8% | +43.6% | -12.1% | -80.7% | +94.3% | -50.3% | +14.9% | +439.6% | +56.7% | -75.5% | -72.1% | -45.1% | |
| Current Ratio | 1.47 | 1.56 | 1.44 | 1.32 | 1.47 | 1.30 | 1.31 | 1.35 | 0.86 | 1.19 | 1.19 | 1.22 | 1.30 | 1.20 | 1.12 | 1.08 | 1.08 | 1.05 | 1.08 | 1.22 | 1.08 |
| — | +19.6% | +9.6% | -2.0% | +72.2% | +9.8% | +9.8% | +9.9% | -34.3% | -0.6% | +6.1% | +13.4% | +20.7% | +14.2% | +3.7% | -11.6% | -0.1% | +6.9% | +9.7% | +11.0% | -0.8% | |
| Quick Ratio | 1.08 | 1.22 | 1.08 | 0.97 | 1.08 | 0.97 | 0.98 | 0.97 | 0.62 | 0.82 | 0.82 | 0.85 | 0.94 | 0.89 | 0.81 | 0.77 | 0.80 | 0.77 | 0.87 | 1.00 | 0.89 |
| — | +26.2% | +10.9% | -0.2% | +75.0% | +18.3% | +18.6% | +13.4% | -34.3% | -8.2% | +1.5% | +11.1% | +17.6% | +15.9% | -6.6% | -23.4% | -9.8% | -1.7% | +9.9% | +13.9% | +2.7% | |
| Interest Coverage | 1.23 | 2.50 | 1.88 | -2.37 | 1.14 | 1.53 | 1.30 | 0.86 | 1.76 | 1.57 | 1.22 | 0.84 | 1.40 | 1.46 | 1.19 | 0.74 | 1.39 | 0.98 | 0.70 | 0.92 | 1.44 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BHC stock.
Bausch Health Companies Inc.'s current P/E is -3.7x. The average P/E over the last 2 quarters is 1.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Bausch Health Companies Inc.'s current operating margin is 21.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Bausch Health Companies Inc.'s business trajectory between earnings reports.